Importantly, the majority (∼75%) of RTT cases are not caused by severe mutations that totally abolish MeCP2 function but rather by mutations that either reduce MeCP2 levels or DNA binding, leading to retention of some partial function of the protein. This evidence concerns the gene MECP2 and Rett syndrome.